The global interventional radiology (IR) market is poised for significant expansion, projected to grow from USD 30,336.0 million in 2025 to USD 49,430.6 million by 2035, reflecting a robust compound annual growth rate (CAGR) of 5.2% during the forecast period. With revenues in 2024 already at USD 28,775.6 million, the interventional radiology sector is emerging as a transformative force in modern healthcare.
Interventional radiology, which focuses on minimally invasive, image-guided medical procedures, is redefining treatment standards across a broad spectrum of clinical applications. From central venous access procedures—which alone account for nearly 40% of annual IR interventions in Europe—to advanced cancer therapies, the scope of IR is expanding rapidly. By combining cutting-edge imaging with catheter- and guidewire-based interventions, interventional radiologists are delivering targeted therapies with enhanced precision and reduced patient discomfort.
Global Interventional Radiology Industry Assessment
| Attribute | Key Insight |
| Historical Market Size, 2024 | USD 28,775.6 million |
| Estimated Market Size, 2025 | USD 30,336.0 million |
| Projected Market Size, 2035 | USD 49,430.6 million |
| CAGR (2025–2035) | 5.2% |
The increasing demand for IR is primarily fueled by the development of new medical technologies, which allow for shorter recovery periods, lower procedural risks, and better outcomes compared to conventional open surgeries. Advancements in catheter technologies, imaging modalities, and specialized medical devices are extending IR applications from vascular interventions to interventional oncology, cardiology, and neurology, ensuring the market remains at the forefront of patient-centered healthcare.
Key Industry Highlights
- Expanding Role of Interventional Oncology (IO): IO is now considered the fourth pillar of cancer care, employing minimally invasive techniques like tumor ablations, embolization therapies, and palliative interventions. Combined with systemic therapies, IO enhances treatment efficacy while minimizing side effects, driving market growth.
- Minimally Invasive Reproductive Treatments: Techniques such as UFE, pelvic venous congestion syndrome treatments, PAE for benign prostatic hyperplasia, and varicocele embolization are increasingly preferred for their reduced recovery times and fertility-preserving advantages.
- AI and Robotics Integration: Smart technologies, including AI-driven imaging, robotic-assisted systems, and real-time navigation software, are enhancing procedural accuracy, reducing risks, and enabling tele-operated interventions in remote regions.
- Skill Shortage: Despite technological advancements, the IR market faces constraints due to the shortage of highly trained specialists and non-uniform training protocols across regions. Bridging this gap through specialized programs is critical for continued growth.
Top Companies Driving Innovation in Interventional Radiology
Leading players are leveraging technology to expand capabilities and improve patient outcomes:
- Siemens Healthineers: Integrates AI and advanced imaging into Artis angiography systems for real-time decision-making and dose optimization.
- GE Healthcare: Allia IGS and Discovery IGS platforms use 3D roadmapping and digital guidance for enhanced procedural safety.
- Philips Healthcare: Azurion platform offers intuitive touch-screen control, smart automation, and integrated navigation.
- Canon Medical Systems: Alphenix systems provide intelligent dose tracking, 4D imaging, and AI-enhanced guidance.
- Intuitive Surgical & Robocath: Robotic interventional systems like Robocath’s R-One allow precise catheter control during cardiovascular interventions.
Market Concentration and Segmentation
- Tier 1 Players: Hold 33.5% of the global market, including Siemens Healthineers, GE Healthcare, Philips Healthcare, and Fujifilm. These companies focus on strategic collaborations and co-development of AI-powered imaging systems.
- Tier 2 Players: Hold 29.1% of the market, including Canon Medical Systems, Hitachi, Hologic, Agfa-Gevaert, Mindray, and United Imaging. These firms innovate in niche areas like interventional oncology and reproductive health.
Country-wise Insights
- United States: Leading North America with a projected CAGR of 2.3% due to strong patient preference for minimally invasive procedures.
- Germany: CAGR of 2.0%, supported by advanced imaging technologies, regulatory backing, and reimbursement policies.
- India: Rapid growth at a CAGR of 7.4%, fueled by medical tourism, healthcare investments, and increasing awareness of non-communicable disease management.
- China: Expected CAGR of 6.9%, reflecting the adoption of state-of-the-art IR technologies in expanding healthcare infrastructure.
Key Segments of the Interventional Radiology Market
By Product:
- MRI Systems (30.5% share, 2025)
- CT Scanners
- Ultrasound Imaging Systems
- Angiography Systems
- Others
By Procedure:
- Angioplasty (23.7% share, 2025)
- Biopsy
- Embolization
- Thrombolysis
- Vertebroplasty
- Nephrostomy
- Interventional Oncology
- MSK Intervention
- Others
By Application:
- Cardiology
- Oncology
- Urology
- Gastroenterology
- Obstetrics & Gynecology
- Others
By End User:
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Others
Recent Developments:
- In December 2024, AGFA HealthCare partnered with Rad AI to enhance radiology workflows using AI-powered reporting and FHIRcast integration.
- In January 2023, Canon Medical Systems USA partnered with ScImage, Inc., to expand cloud-native enterprise image management solutions.
This Report Now at Just $5000 | Limited-Time Discount Offer! https://www.futuremarketinsights.com/reports/sample/rep-gb-14344
Checkout Now to Access Industry Insights: https://www.futuremarketinsights.com/checkout/14344
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
